Richard J Hawkins Insider Trading
Get free email notifications about insider trading for Richard J Hawkins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard J Hawkins. Richard J Hawkins is a Director in SCICLONE PHARMACEUTICALS INC ($SCLN) and a Director in CYTORI THERAPEUTICS, INC. ($XMP) and a Director in Savara Inc ($MSTX) and an Chief Executive Officer in LUMOS PHARMA, INC. ($NLNK).
Address: 901 MARINERS ISLAND BLVD., SUITE 205 SAN MATEO 94404 CA
Companies in which Richard J Hawkins is an Insider
LUMOS PHARMA, INC.
Trading Symbol: NLNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard J Hawkins: Chief Executive Officer
Holdings: 745,382 shares
Current Value: $10,189,372
Latest Transaction: Apr 05 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PLUS THERAPEUTICS, INC.
Trading Symbol: PSTVIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Richard J Hawkins: Director
Holdings: 8,435 shares
Latest Transaction: Jun 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Savara Inc
Trading Symbol: SVRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard J Hawkins: Director
Holdings: 21,682 shares
Current Value: $3,035
Latest Transaction: Dec 17 2020
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCICLONE PHARMACEUTICALS INC
Trading Symbol: SCLNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard J Hawkins: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 16 2017
$SCLN Market Capitalization: $495.21M
$SCLN Previous Close: $9.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard J Hawkins
Sentiment: All, NLNK, PSTV, SVRA, SCLN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Payment of Exercise | F | 12.25 | 1,522 | 18,645 | 745,382 | 746.9 K to 745.4 K (-0.20 %) |
Dec 17 2020 | SVRA | Savara Inc | Hawkins Richard J | Director | Option Exercise | A | 1.23 | 40,000 | 49,200 | 40,000 | |
Jun 29 2020 | PSTV | PLUS THERAPEUTICS, ... | Hawkins Richard J | Director | Option Exercise | A | 2.10 | 40,000 | 84,000 | 40,000 | |
Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Option Exercise | A | 7.87 | 135,000 | 1,062,450 | 135,000 | |
Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 744,575 | 719.6 K to 744.6 K (+3.47 %) |
Dec 26 2019 | SVRA | Savara Inc | Hawkins Richard J | Director | Option Exercise | A | 1.59 | 12,000 | 19,080 | 12,000 | |
May 16 2019 | SVRA | Savara Inc | Hawkins Richard J | Director | Option Exercise | M | 0.55 | 444 | 244 | 728 |